JPMorgan Chase & Co. reiterated their underweight rating on shares of GSK (LON:GSK – Free Report) in a research note published on Thursday morning, Marketbeat.com reports. A number of other analysts have also recently weighed in on the company. Shore Capital restated a buy rating on shares of GSK in a research note on Friday, […]